Impact of scale on the effectiveness of disease control strategies for epidemics with cryptic infection in a dynamical landscape: an example for a crop disease CA Gilligan, JE Truscott, AJ Stacey Journal of the Royal Society Interface 4 (16), 925-934, 2007 | 80 | 2007 |
A model for the invasion and spread of rhizomania in the United Kingdom: implications for disease control strategies AJ Stacey, JE Truscott, MJC Asher, CA Gilligan Phytopathology 94 (2), 209-215, 2004 | 61 | 2004 |
A novel automated bioreactor for scalable process optimisation of haematopoietic stem cell culture E Ratcliffe, KE Glen, VL Workman, AJ Stacey, RJ Thomas Journal of biotechnology 161 (3), 387-390, 2012 | 54 | 2012 |
Candida albicans hyphal invasion: thigmotropism or chemotropism? JM Davies, AJ Stacey, CA Gilligan FEMS microbiology letters 171 (2), 245-249, 1999 | 44 | 1999 |
The productivity limit of manufacturing blood cell therapy in scalable stirred bioreactors R Bayley, F Ahmed, K Glen, M McCall, A Stacey, R Thomas Journal of tissue engineering and regenerative medicine 12 (1), e368-e378, 2018 | 36 | 2018 |
Soil-borne fungal pathogens: scaling-up from hyphal to colony behaviour and the probability of disease transmission AJ Stacey, JE Truscott, CA Gilligan New Phytologist, 169-177, 2001 | 27 | 2001 |
Effective information retrieval from the internet: an advanced user’s guide A Stacey, A Stacey Elsevier, 2004 | 24 | 2004 |
Production of erythrocytes from directly isolated or Delta1 Notch ligand expanded CD34+ hematopoietic progenitor cells: process characterization, monitoring and implications … KE Glen, VL Workman, F Ahmed, E Ratcliffe, AJ Stacey, RJ Thomas Cytotherapy 15 (9), 1106-1117, 2013 | 22 | 2013 |
A mechanistic model of erythroblast growth inhibition providing a framework for optimisation of cell therapy manufacturing KE Glen, EA Cheeseman, AJ Stacey, RJ Thomas Biochemical Engineering Journal 133, 28-38, 2018 | 20 | 2018 |
Experimentally integrated dynamic modelling for intuitive optimisation of cell based processes and manufacture AJ Stacey, EA Cheeseman, KE Glen, RLL Moore, RJ Thomas Biochemical engineering journal 132, 130-138, 2018 | 10 | 2018 |
Visualizing medium and biodistribution in complex cell culture bioreactors using in vivo imaging E Ratcliffe, RJ Thomas, AJ Stacey Biotechnology Progress 30 (1), 256-260, 2014 | 6 | 2014 |
Bioreactor consumable units AN Bargh, AJ Stacey, SK Sullivan US Patent 10,329,524, 2019 | 3 | 2019 |
Bioreactor vessel AN Bargh, AJ Stacey, SK Sullivan US Patent App. 29/530,428, 2016 | 3 | 2016 |
Modeling the selective growth advantage of genetically variant human pluripotent stem cells to identify opportunities for manufacturing process control C Beltran-Rendon, CJ Price, K Glen, A Stacey, I Barbaric, RJ Thomas Cytotherapy, 2024 | 1 | 2024 |
Computer-implemented method and system for spectroscopic analysis of biological material A Stacey, C Grimm, M Hoehse, T Regen, A Woodhams US Patent 11,598,720, 2023 | 1 | 2023 |
Scaling tool A Stacey, J Scholz US Patent 11,429,911, 2022 | 1 | 2022 |
Understanding cell culture medium dynamics as a key stepping stone to optimistation of cell therapy bioprocessing KE Glen, A Stacey, RJ Thomas Cytotherapy 22 (5), S145, 2020 | 1 | 2020 |
Auto-aligning cable sensor A Stacey, D Huttlestone, E Grace US Patent 11,874,287, 2024 | | 2024 |
Scaling tool A Stacey, J Scholz US Patent 11,687,856, 2023 | | 2023 |
Computer-implemented method and system for spectroscopic analysis of biological material A Stacey, C Grimm, M Hoehse, T Regen, A Woodhams US Patent App. 18/106,958, 2023 | | 2023 |